Zykadia

Drug List

Zykadia

Drug Name

Zykadia (Ceritinib)

Manufactured By

Novartis Pharmaceuticals Corporation

Drug Savings

Nationwide Prescription Connection (NPC) is an experienced advocacy service that helps connect patients to manufacturer provided free and discount programs. We can help the uninsured, under insured, those in the Medicare gap also known as the "doughnut hole", or even those needing help with expensive co-pays.  Our web site makes it easy for you to enter the medications you are taking, along with some basic patient information, and then finds the program that is right for you.

NPC's mission is your health. We recognize your need for help when you are applying for discount programs for your prescription medications. We consist of friendly and experienced advocates that not only know how these free and discount programs work, but are ready to help. We are available to take your call and answer any questions you may have as you search for the right program to fit your needs. We can also explain any supporting material you may need to provide as you apply for these programs. If for any reason you are denied, we also are experienced in the best appeals process with a high success rate.

Treats Disease/Condition

Uses

Ceritinib (trade name Zykadia) is a drug for the treatment of a specific type of lung cancer.[1] It is an anaplastic lymphoma kinase (ALK) inhibitor.[2] It was approved in April 2014 by the Food and Drug Administration for the treatment of ALK-positive metastatic non-small cell lung cancer (NSCLC) following treatment with crizotinib

How To Use

Zykadia™ is a capsule, taken by mouth: the standard starting dose is 5 capsules, once daily. It should be taken on an empty stomach (do not eat for 2 hours before and 2 hours after your dose). Take Zykadia™ exactly as prescribed. Swallow Zykadia™ capsules whole. Do not crush, dissolve or open capsules. Do not change your dose or stop Zykadia™ unless your health care provider tells you to. If you miss a dose, take it as soon as you remember. If your next dose is due within 12 hours, then skip the missed dose. Take the next dose at the regular time. Do not take more than 1 dose of Zykadia™ at one time. Call your health care provider right away if you take too much. You should not drink grapefruit juice or eat grapefruit during your treatment with Zykadia™. It may make the amount of Zykadia™ in your blood increase to a harmful level. The amount of Zykadia™ that you will receive depends on many factors, your general health or other health problems, and the type of cancer or condition being treated.

Side Effects

The following side effects are common (occurring in greater than 30%) for patients taking Zykadia™: Diarrhea, Hemoglobin decreased, Increase in liver enzymes, Nausea, Vomiting, Increase in creatinine, Abdominal pain, Fatigue, Glucose increased, Decrease in phosphate, Decreased appetite, Constipation, Lipase increased, Esophageal disorder (Heart burn, dyspepsia, dysphagia), Rash

Drug Interactions

Strong CYP3A Inhibitors, Strong CYP3A Inducers,

In Case of Overdose

Seek medical attention

In Case of Missed Dose

If you miss a dose, take it as soon as you remember. If your next dose is due within 12 hours, then skip the missed dose. Take the next dose at the regular time.

Storage

Store at 25°C (77°F); excursions permitted between 15°C to 30°C (59°F to 86°F)